Guidance

Levobupivacaine: informing intrathecal risk assessment

11 August 2022Levobupivacaine products vary in their licensed status and other characteristics which affects their suitability for intrathecal administration

Vancomycin: informing intrathecal risk assessment

11 August 2022Vancomycin products vary in their licensed status and other characteristics which affects their suitability for intrathecal administration

Amikacin: informing intrathecal risk assessment

11 August 2022Amikacin products vary in their licensed status and other characteristics which affects their suitability for intrathecal administration

Thiotepa: informing intrathecal risk assessment

11 August 2022Thiotepa products vary in their licensed status and other characteristics which affects their suitability for intrathecal administration

Guidance

Clinical Trials

Advice and guidance to support the provision of pharmacy clinical trials services.

Medication Restrictions for Patients Having CAR-T Cell Therapy V5

12 July 2022CAR-T Therapy requires some medicines to be restricted, this guidance provides details and recommended wash-out periods for restricted medicines.

Costing Clinical Trials of ATIMPs using the NIHR iCT - Advice for Pharmacy Sites

12 July 2022Guidance to support and promote consistent pharmacy costing for commercial clinical trials involving ATIMPs.

Supportive Medicines for Adults Receiving Marketed CAR-T Cell Therapy

12 July 2022This document provides expert clinical pharmacy guidance on supportive medicines in order to facilitate the treatment of complex CAR-T Cell Therapy patients.

Compatibility of nebuliser solution combinations

22 June 2022Guidance on what to consider when mixing nebuliser solutions and advice on which combinations are compatible.

Using warfarin with proton pump inhibitors (PPIs)

17 June 2022PPIs may enhance warfarin anticoagulation. Patients on warfarin require counselling when starting on a PPI and INR monitored appropriately.

SPS - Specialist Pharmacy Service

NHS